NCT00682461View on ClinicalTrials.gov

Oral Tolerability Of Two Nicotine Dosage Forms

PHASE1CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions

Healthy Volunteer Smokers

Interventions

DRUG

Nicotine

Marketed nicotine replacement therapy formulation

DRUG

Nicotine

Nicotine prototype

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY